The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases

Akram Shariati1, Venus Shahabi Raberi2, Mehdi Masumi2

  • 1Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

PubMed

Insights

MicroRNAs (miRNAs) regulate programmed cell death pathways like pyroptosis and ferroptosis, impacting cardiovascular diseases (CVDs). Understanding this crosstalk offers potential new therapeutic strategies for heart failure.

Area of Science:

  • Biomedical science
  • Molecular biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of death.
  • MicroRNAs (miRNAs) are key regulators of cellular processes, including metabolism, homeostasis, and programmed cell death (PCD).
  • Pyroptosis and ferroptosis are critical non-apoptotic PCD types implicated in heart failure pathogenesis.

Purpose of the Study:

  • To review the intricate relationship between miRNAs and pyroptosis and ferroptosis in the context of CVDs.
  • To explore how miRNAs modulate these specific PCD pathways in cardiovascular disease.
  • To identify potential therapeutic targets within miRNA-regulated PCD pathways for CVD treatment.

Main Methods:

  • Comprehensive literature review of studies investigating miRNAs, pyroptosis, ferroptosis, and CVDs.
  • Analysis of existing research on the regulatory roles of miRNAs in non-apoptotic cell death.
  • Synthesis of findings to elucidate the crosstalk between miRNAs and PCD in cardiovascular pathogenesis.

Main Results:

  • Evidence indicates that various miRNAs can regulate both pyroptosis and ferroptosis.
  • These miRNA-mediated regulatory actions influence the progression and inhibition of CVDs.
  • The interplay between miRNAs and these PCDs is a significant factor in heart failure development.

Conclusions:

  • The crosstalk between miRNAs and pyroptosis/ferroptosis pathways is crucial in CVDs.
  • Targeting these miRNA-regulated PCD pathways presents a promising avenue for novel therapeutic interventions.
  • Further research is warranted to validate these pathways as effective therapeutic strategies against cardiovascular diseases.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K